Detalhe da pesquisa
1.
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force.
Ann Rheum Dis
; 82(6): 788-798, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627168
2.
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models.
Rheumatology (Oxford)
; 60(4): 1891-1901, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146389
3.
Treatment of Calcinosis in Juvenile Dermatomyositis.
Curr Rheumatol Rep
; 23(2): 13, 2021 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555459
4.
Consensus-based recommendations for the management of juvenile localised scleroderma.
Ann Rheum Dis
; 78(8): 1019-1024, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826775
5.
Juvenile dermatomyositis: novel treatment approaches and outcomes.
Curr Opin Rheumatol
; 30(6): 650-654, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30124602
6.
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.
Ann Rheum Dis
; 77(2): 241-250, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29084729
7.
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.
Ann Rheum Dis
; 77(8): 1107-1117, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29592918
8.
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative.
Ann Rheum Dis
; 76(10): 1637-1641, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473426
9.
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.
Ann Rheum Dis
; 76(12): 1965-1973, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28877866
10.
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Ann Rheum Dis
; 76(5): 782-791, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28385804
11.
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.
Rheumatology (Oxford)
; 56(11): 1884-1893, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28977549
12.
Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease.
Ann Rheum Dis
; 74(1): 204-10, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24064003
13.
Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years.
Arthritis Rheum
; 65(9): 2476-85, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23754739
14.
A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies.
Rheumatology (Oxford)
; 50(1): 137-45, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20823094
15.
Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison.
RMD Open
; 7(3)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34531304
16.
Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood.
Rheumatology (Oxford)
; 49(8): 1505-12, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20430869
17.
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients.
Arthritis Res Ther
; 22(1): 79, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293539
18.
Juvenile dermatomyositis: extramuscular manifestations and their management.
Curr Opin Rheumatol
; 21(6): 575-80, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19730375
19.
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Arthritis Rheumatol
; 70(5): 785-793, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29342499
20.
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Arthritis Rheumatol
; 69(5): 911-923, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28382778